Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1995-06-07
1999-10-19
Dees, Jos' G.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
534 14, 424 165, 424 111, 530300, 530311, 530330, A61K 5100, A61M 3614
Patent
active
059684763
ABSTRACT:
This invention relates to radiolabeled peptides and methods for producing such peptides. Specifically, the invention relates to specific binding peptides, methods and kits for making such peptides, and methods for using such peptides labeled with technetium-99m via a radiolabel-binding moiety covalently linked to the peptide to image thrombus sites in a mammalian body.
REFERENCES:
patent: 4578079 (1986-03-01), Rouslahti et al.
patent: 4792525 (1988-12-01), Rouslahti et al.
patent: 4957903 (1990-09-01), Ranby
patent: 5086069 (1992-02-01), Klein et al.
patent: 5190920 (1993-03-01), Eyal et al.
patent: 5217705 (1993-06-01), Reno et al.
patent: 5270030 (1993-12-01), Vogel et al.
patent: 5328840 (1994-07-01), Coller
patent: 5371184 (1994-12-01), Rajagopalan et al.
patent: 5372933 (1994-12-01), Zamarron et al.
patent: 5380646 (1995-01-01), Knight et al.
patent: 5395609 (1995-03-01), Stuttle
patent: 5443815 (1995-08-01), Dean et al.
patent: 5443816 (1995-08-01), Zamora et al.
patent: 5492890 (1996-02-01), Ginsberg et al.
patent: 5506208 (1996-04-01), Eyal et al.
patent: 5508020 (1996-04-01), Dean et al.
patent: 5736122 (1998-04-01), Dean et al.
patent: 5744120 (1998-04-01), Edwards et al.
patent: 5849260 (1998-12-01), Dean et al.
Parise & Phillips, 1985, "Reconstitution of the Purified Platelet Fibrinogen Receptor: Fibrinogen Binding Properties of the Glycoprotein IIb-IIIa Complex", J. Biol. Chem. 260: 10698-10707.
Knight, 1990, "Radiopharmceuticals for Thrombus Detection", Sem. Nucl. Med. 20: 52-67.
Baidoo & Lever, 1990, "Synthesis of a Diaminedithiol Bifunctional Chelating Agent for Incorporation of Technetium-99m into Biomolecules", Bioconjugate Chem. 1: 132-137.
Bryson et al., 1990, "Protecting Groups in the Preparation of Thiolate Complexes of Technetium", Inorganic Chem. 292948-2951.
Ojima et al., 1992, "Design and Synthesis of New RGD Peptides as Inhibitors of Human Platelet Aggregation", 204th Meeting, Amer. Chem. Soc. Abst. 44.
Hartman et al., 1992, "Non-peptide Fibrinogen Receptor Antagonists. 1. Discovery and Design of Exosite Inhibitors", J. Med. Chem. 35: 4640-4642.
Fritzburg, et al. "Specific and Stable Labeling of Antibodies with Technetium-99m with a Diamide dithioate chelating agent" Proc. Natl. Acad. Sci. 85:4025-4029 (1981).
Pearson, et al. "Thrombus imaging using technitium-99m-labeled high-potency GPIIb/IIIa receptor antagonists. Chemistry and initial biological studies." J. Med. Chem. 39: 1372-1382.
Pearson et al (1996), J. Med. Chem, vol. 39, No. 7, pp. 1372-1382, "Thrombus Imaging Using Technetium-99m labeled High Potency GPIIb/IIIa Receptor Antagonists. Chemistry and Initial Biological Studies.".
Dean Richard T.
Lister-James John
Dees Jos' G.
Diatide, Inc.
Jones Dameron
McDaniels Patricia A.
Noonan Kevin E.
LandOfFree
Technetium-99m labeled peptides for thrombus imaging does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Technetium-99m labeled peptides for thrombus imaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Technetium-99m labeled peptides for thrombus imaging will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2051904